HEADER TRANSFERASE/INHIBITOR 23-AUG-18 6M9L TITLE STRUCTURE-BASED DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF TITLE 2 IMIDAZO[4,5-B]PYRIDINE-2-ONE BASED P38 MAP KINASE INHIBITORS BY TITLE 3 SCAFFOLD HOPPING - COMPOUND 10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG-BINDING COMPND 5 PROTEIN,CSBP,MAP KINASE MXI2,MAX-INTERACTING PROTEIN 2,MITOGEN- COMPND 6 ACTIVATED PROTEIN KINASE P38 ALPHA,MAP KINASE P38 ALPHA,STRESS- COMPND 7 ACTIVATED PROTEIN KINASE 2A,SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS SBDD, STRUCTURE BASED DRUG DESIGN, P38, KINASE, TRANSFERASE, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.LANE,K.OKADA REVDAT 3 13-MAR-24 6M9L 1 REMARK REVDAT 2 29-MAY-19 6M9L 1 JRNL REVDAT 1 17-APR-19 6M9L 0 JRNL AUTH A.KAIEDA,M.TAKAHASHI,H.FUKUDA,R.OKAMOTO,S.MORIMOTO,M.GOTOH, JRNL AUTH 2 T.MIYAZAKI,Y.HORI,S.UNNO,T.KAWAMOTO,T.TANAKA,S.ITONO, JRNL AUTH 3 T.TAKAGI,H.SUGIMOTO,K.OKADA,G.SNELL,R.BERTSCH,J.NGUYEN, JRNL AUTH 4 B.C.SANG,S.MIWATASHI JRNL TITL STRUCTURE-BASED DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION JRNL TITL 2 OF IMIDAZO[4,5-B]PYRIDIN-2-ONE-BASED P38 MAP KINASE JRNL TITL 3 INHIBITORS: PART 1. JRNL REF CHEMMEDCHEM V. 14 1022 2019 JRNL REFN ESSN 1860-7187 JRNL PMID 30945818 JRNL DOI 10.1002/CMDC.201900129 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.38 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 13409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 672 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.3900 - 4.2000 1.00 2778 121 0.1951 0.2434 REMARK 3 2 4.2000 - 3.3300 1.00 2657 123 0.1910 0.2355 REMARK 3 3 3.3300 - 2.9100 1.00 2568 162 0.2265 0.3128 REMARK 3 4 2.9100 - 2.6400 0.97 2505 138 0.2476 0.2957 REMARK 3 5 2.6400 - 2.4500 0.87 2229 128 0.2649 0.2967 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.263 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.017 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.22 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2750 REMARK 3 ANGLE : 0.633 3736 REMARK 3 CHIRALITY : 0.038 419 REMARK 3 PLANARITY : 0.003 485 REMARK 3 DIHEDRAL : 11.059 1644 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6M9L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1000236390. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13411 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 49.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.15960 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.51720 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.760 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24.% PEG MME 5000, 0.1M MES_NA, PH REMARK 280 7.4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.2K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.33700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.28100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.52300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.28100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.33700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.52300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -27 REMARK 465 SER A -26 REMARK 465 TYR A -25 REMARK 465 TYR A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 ASP A -17 REMARK 465 TYR A -16 REMARK 465 ASP A -15 REMARK 465 ILE A -14 REMARK 465 PRO A -13 REMARK 465 THR A -12 REMARK 465 THR A -11 REMARK 465 GLU A -10 REMARK 465 ASN A -9 REMARK 465 LEU A -8 REMARK 465 TYR A -7 REMARK 465 PHE A -6 REMARK 465 GLN A -5 REMARK 465 GLY A -4 REMARK 465 ALA A -3 REMARK 465 MET A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 ALA A 34 REMARK 465 LEU A 171 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 ALA A 184 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 35 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 GLN A 120 CG CD OE1 NE2 REMARK 470 MET A 198 CG SD CE REMARK 470 HIS A 199 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 149 -19.92 72.28 REMARK 500 ASP A 150 61.16 -151.31 REMARK 500 ASP A 227 -157.62 -138.93 REMARK 500 LEU A 289 42.12 -102.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J9G A 501 DBREF 6M9L A 1 360 UNP Q16539 MK14_HUMAN 1 360 SEQADV 6M9L MET A -27 UNP Q16539 EXPRESSION TAG SEQADV 6M9L SER A -26 UNP Q16539 EXPRESSION TAG SEQADV 6M9L TYR A -25 UNP Q16539 EXPRESSION TAG SEQADV 6M9L TYR A -24 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -23 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -22 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -21 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -20 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -19 UNP Q16539 EXPRESSION TAG SEQADV 6M9L HIS A -18 UNP Q16539 EXPRESSION TAG SEQADV 6M9L ASP A -17 UNP Q16539 EXPRESSION TAG SEQADV 6M9L TYR A -16 UNP Q16539 EXPRESSION TAG SEQADV 6M9L ASP A -15 UNP Q16539 EXPRESSION TAG SEQADV 6M9L ILE A -14 UNP Q16539 EXPRESSION TAG SEQADV 6M9L PRO A -13 UNP Q16539 EXPRESSION TAG SEQADV 6M9L THR A -12 UNP Q16539 EXPRESSION TAG SEQADV 6M9L THR A -11 UNP Q16539 EXPRESSION TAG SEQADV 6M9L GLU A -10 UNP Q16539 EXPRESSION TAG SEQADV 6M9L ASN A -9 UNP Q16539 EXPRESSION TAG SEQADV 6M9L LEU A -8 UNP Q16539 EXPRESSION TAG SEQADV 6M9L TYR A -7 UNP Q16539 EXPRESSION TAG SEQADV 6M9L PHE A -6 UNP Q16539 EXPRESSION TAG SEQADV 6M9L GLN A -5 UNP Q16539 EXPRESSION TAG SEQADV 6M9L GLY A -4 UNP Q16539 EXPRESSION TAG SEQADV 6M9L ALA A -3 UNP Q16539 EXPRESSION TAG SEQADV 6M9L MET A -2 UNP Q16539 EXPRESSION TAG SEQADV 6M9L GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 6M9L SER A 0 UNP Q16539 EXPRESSION TAG SEQADV 6M9L SER A 162 UNP Q16539 CYS 162 CONFLICT SEQRES 1 A 388 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 388 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 388 GLY SER MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN SEQRES 4 A 388 GLU LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR SEQRES 5 A 388 GLN ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER SEQRES 6 A 388 VAL CYS ALA ALA PHE ASP THR LYS THR GLY LEU ARG VAL SEQRES 7 A 388 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE SEQRES 8 A 388 HIS ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS SEQRES 9 A 388 HIS MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL SEQRES 10 A 388 PHE THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL SEQRES 11 A 388 TYR LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN SEQRES 12 A 388 ILE VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN SEQRES 13 A 388 PHE LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 14 A 388 HIS SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 15 A 388 ASN LEU ALA VAL ASN GLU ASP SER GLU LEU LYS ILE LEU SEQRES 16 A 388 ASP PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR SEQRES 17 A 388 GLY TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE SEQRES 18 A 388 MET LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE SEQRES 19 A 388 TRP SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY SEQRES 20 A 388 ARG THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU SEQRES 21 A 388 LYS LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU SEQRES 22 A 388 LEU LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR SEQRES 23 A 388 ILE GLN SER LEU THR GLN MET PRO LYS MET ASN PHE ALA SEQRES 24 A 388 ASN VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU SEQRES 25 A 388 LEU GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE SEQRES 26 A 388 THR ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN SEQRES 27 A 388 TYR HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR SEQRES 28 A 388 ASP GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU SEQRES 29 A 388 TRP LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL SEQRES 30 A 388 PRO PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET J9G A 501 26 HETNAM J9G 3-BENZYL-6-[(2,4-DIFLUOROPHENYL)AMINO]-1,3-DIHYDRO-2H- HETNAM 2 J9G IMIDAZO[4,5-B]PYRIDIN-2-ONE FORMUL 2 J9G C19 H14 F2 N4 O FORMUL 3 HOH *156(H2 O) HELIX 1 AA1 SER A 61 MET A 78 1 18 HELIX 2 AA2 THR A 123 ALA A 144 1 22 HELIX 3 AA3 LYS A 152 SER A 154 5 3 HELIX 4 AA4 ALA A 190 LEU A 195 1 6 HELIX 5 AA5 THR A 203 GLY A 219 1 17 HELIX 6 AA6 ASP A 227 GLY A 240 1 14 HELIX 7 AA7 GLY A 243 LYS A 248 1 6 HELIX 8 AA8 SER A 252 LEU A 262 1 11 HELIX 9 AA9 ASN A 269 VAL A 273 5 5 HELIX 10 AB1 ASN A 278 LEU A 289 1 12 HELIX 11 AB2 THR A 298 ALA A 304 1 7 HELIX 12 AB3 HIS A 305 ALA A 309 5 5 HELIX 13 AB4 GLN A 325 ARG A 330 5 6 HELIX 14 AB5 LEU A 333 SER A 347 1 15 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O THR A 16 N LEU A 13 SHEET 1 AA2 5 TYR A 24 GLY A 31 0 SHEET 2 AA2 5 GLY A 36 ASP A 43 -1 O ALA A 40 N SER A 28 SHEET 3 AA2 5 ARG A 49 LEU A 55 -1 O VAL A 52 N CYS A 39 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 3 ALA A 111 ASP A 112 0 SHEET 2 AA3 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA3 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 15 VAL A 30 VAL A 38 ALA A 51 VAL A 52 SITE 2 AC1 15 LYS A 53 LEU A 104 VAL A 105 THR A 106 SITE 3 AC1 15 HIS A 107 LEU A 108 MET A 109 GLY A 110 SITE 4 AC1 15 ALA A 111 LEU A 167 HOH A 643 CRYST1 68.674 71.046 74.562 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014562 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014075 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013412 0.00000